← Leaderboards
Florian Douam
Boston University Medical Campus
$1,233,116
Attributed
$1,889,697
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,889,697 · 4
By mechanism
R21$894,275 · 2
R01$651,384 · 1
K22$344,038 · 1
Top collaborators
- Jennifer J Schlezinger2 shared
- Mark W Grinstaff1 shared
- Ahmad Samir Khalil1 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Thomas William Geisbert$89,759,942
- Jennifer J Schlezinger$3,855,025
- Philippe Adam Grandjean$27,466,501
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsProteinsInfectionVirusMouse ModelImmune SystemHumanized MousePathogenIn VivoBindingViralUnited States National Institutes Of HealthProgramsVaccinationBloodPathogenic VirusCostDengue VirusNucleotidesPhysiologicalMedicalClinical ManagementCulicidaeMolecular
Grant awards (7)
A self-amplifying RNA-based synthetic nanobody platform for next-generation therapeutics$651,384
R01 · FY2025 · EB
Human cutaneous responses to arthropod-mediated viral transmission$449,625
R21 · FY2025 · AI · contact PI
Characterization of a human-specific positive regulator of flavivirus infection$75,600
K22 · FY2023 · AI · contact PI
Defining the Impact of Per/Polyfluoroalkyl Substance Exposure on Susceptibility to SARS-CoV-2 Infection and Disease$201,700
R21 · FY2022 · ES
Characterization of a human-specific positive regulator of flavivirus infection$106,438
K22 · FY2022 · AI · contact PI
Defining the Impact of Per/Polyfluoroalkyl Substance Exposure on Susceptibility to SARS-CoV-2 Infection and Disease$242,950
R21 · FY2021 · ES
Characterization of a human-specific positive regulator of flavivirus infection$162,000
K22 · FY2021 · AI · contact PI